FIRST ADDENDUM TO THE LICENSE AGREEMENT

FIRST ADDENDUM TO THE LICENSE AGREEMENT

AND COMMERCIAL TERM SHEET Between

FILAMENT HEALTH CORP. a corporation incorporated

in British Columbia Canada, with offices at #210-4475 Wayburne Drive, Burnaby BC ("Filament")

PSYENCE GROUP INC, a corporation

incorporated in Ontario, Canada, with offices at 121 Richmond Street West Penthouse Suite, 1300 Toronto, ON M5H2K1, Canada (an amalgamation

between PSYENCE GROUP INC AND PSYENCE BIOMED CORP) ("PSYG")

(collectively, the "Parties")

The Shipment consists of the following:

The Term Sheet is hereby terminated with effect from the

The License Agreement is hereby amended

the extent specifically or by necessary implication modified in or inconsistent with the provisions of this Addendum, all the terms and

conditions of the License Agreement shall mutatis mutandis continue in full force and effect. If there is any discrepancy between

this Addendum and the License Agreement, this Addendum shall prevail.

Each Party will bear and pay its own legal costs and expenses

of and incidental to the negotiation, drafting, preparation and implementation of this Addendum.

Signed on behalf of the parties, each signatory hereto

warranting that he/she has due authority to do so.

IN WITNESS WHEREOF the parties have executed this

Addendum as of the date first written above.